Filter by: patients
Home > Community Treatment Reports and Side Effects > Diamicron Treatment Report
What is Diamicron?

Diamicron® is a Canadian brand name for the antidiabetic agent gliclazide. It is used for the management of type 2 diabetes mellitus.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Diabetes Type 2 5 0
Increase effect of another treatment 1 0

See all 7 patients currently taking Diamicron

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 1
None
 0

Reported Dosages

  30 mg daily 60 mg daily 80 mg daily 120 mg daily 160 mg daily
  2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Diamicron

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Diamicron

Always
 0 0%
Usually
 1 100%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Diamicron

Very
 0 0%
Somewhat
 1 100%
A little
 0 0%
Not at all
 0 0%

Cost

Paid out of pocket

Cost of Diamicron

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 1 100%

Report created on May 28, 2012.